Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins.
about
Dehydroepiandrosterone (DHEA) supplementation results in supraphysiologic DHEA-S serum levels and progesterone assay interference that may impact clinical management in IVFEndometrial receptivity profile in patients with premature progesterone elevation on the day of HCG administration.Serum progesterone on the day of human chorionic gonadotropin administration predicts clinical pregnancy of sibling frozen embryos.Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update.Elevated serum progesterone/ MII oocyte ratio on the day of human chorionic gonadotropin administration can predict impaired endometrial receptivityGnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.Comparison of results of cycles treated with modified mild protocol and short protocol for ovarian stimulation.Reproducibility and clinical significance of pre-ovulatory serum progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in infertile women undergoing repeated in vitro fertilization cyclesProgesterone/Estradiol Ratio as a Predictor in the ART Cycles with Premature Progesterone Elevation on the Day of hCG Trigger.Serum progesterone levels greater than 20 ng/dl on day of embryo transfer are associated with lower live birth and higher pregnancy loss rates.A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles.Relationship between progesterone level on the day of human chorionic gonadotropin administration with outcomes of intra-cytoplasmic sperm injection in infertile couples.Preretrieval predictors of pregnancy in IVF.Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women.The effects of gonadotropin-releasing hormone agonist on androstenedione production and follicular development during controlled ovarian hyperstimulation.Expression of integrin fraction and adhesion molecules on human granulosa cells and its relation with oocyte maturity and follicular steroidogenesis.Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration.Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis.Does subtle progesterone rise on the day of HCG affect pregnancy rate in long agonist ICSI cycles?Preovulatory progesterone rise during ovarian stimulation for IVF.Follicular progesterone elevations with ovulation induction for IVF.Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis.Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist?Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer?Elevated progesterone and its impact on birth weight after fresh embryo transfers.Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration.Elevated progesterone in GnRH agonist down regulated in vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality.Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.Intranasal nafarelin versus buserelin (short protocol) for controlled ovarian hyperstimulation before in vitro fertilization: a prospective clinical trial.The significance of serum progesterone levels on the day of hCG administration on IVF pregnancy rates.The Impact of Progesterone Level on Day Of hCG Injection in IVF Cycles on Clinical Pregnancy Rate.The significance of premature luteinization in an oocyte-donation programme.Elevated progesterone-to-estradiol ratio versus serum progesterone alone for predicting poor cycle outcome with in vitro fertilization.Low dose gonadotropin-releasing hormone agonist treatments with early discontinuation for controlled ovarian hyperstimulation in an in vitro fertilization program.The curious case of premature luteinizationBasal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles
P2860
Q30277765-C2107B19-2CA7-49F6-B15F-91F220213951Q33616493-0F945C1C-4E6E-4129-9FBF-B21FCFD53CAFQ33622221-1D58FEE4-3D18-40BF-AFBC-A076DC13EB4AQ33790874-3A2259D9-EE3E-4489-9E6B-217720806733Q33953801-33FF1267-3B32-4CB8-AAFE-FD79CC4F7BC5Q34636679-B565A925-656E-4DEA-910D-792EBEED45B7Q35100104-111B41FF-0FE9-4291-9A83-6DD13C666607Q35626819-05112C1C-36B6-4D35-83CB-A90472B663F9Q35868487-168DCDA3-D878-4A60-99B2-E39223068F4CQ36127719-F166530A-C0EC-40DF-932E-03BB104490E9Q36152311-8DD11025-AB87-4C8D-A471-61D3984FCB23Q36172763-721D502A-1593-4D8B-95C5-91ECD643F03BQ36267332-8C578CA5-7B8E-45B5-81D2-38F282EBF4D1Q36267478-43A5E2F9-704F-4FDC-A8EC-5D01429EADE4Q36268805-FBA818F2-3394-4445-BE42-AFCFA12243B4Q36269586-5579D9F8-68AF-41E0-9C00-274815F5E106Q36484614-F534BADB-AEED-4DA9-8145-0464898FB5B2Q36779164-AFAB81E6-AD0C-40E9-B479-105709ABB3FAQ37284474-A3287203-93C1-413A-B7F9-4909CF35881AQ38112759-239F900A-B7B1-42A8-91D6-A351B2D346FBQ38212903-5A517E2E-FBF3-48A7-8CF0-21617B8B888CQ42741040-C614E123-D8F5-4618-86A5-5829E4606661Q43293874-E7E1E69F-20FC-451F-AE51-2F7E26A40CF1Q46145084-3D8369FE-29C2-4E5D-B608-BC5C1BF3DFB2Q46470142-033B1BAB-CA09-4372-9882-3383D6831184Q47220243-7D9CFD65-F7F2-40F1-8F59-62A7238F237DQ48600092-D7143413-C792-4963-835A-8E0800DCA19CQ48666431-59247C65-AFD4-4E3E-AC57-39037C325E82Q48787898-CEC6AF2D-6A5C-419F-8B53-6439B0D8E8D1Q48986568-EDBA007B-746D-4A59-B5F2-FB47BC38327CQ49103648-70D763B6-57C6-4359-AC22-CC01D679B0E1Q49412101-1E24F868-A74C-4871-B7C5-F71E4CBFEF3AQ50649852-FF370858-4FAA-408E-BCF0-E84C4ACF2E73Q50966721-B62C9514-2990-485E-94A0-ABBC8EACF5D0Q55069292-D4D2CF4C-46AB-48AA-ABBD-5B8228908725Q57141004-9B97150C-97DC-4C25-A5A8-1C7FBD8D9AEBQ58860558-E5F63086-B7B2-413C-9D01-52860CE761A1
P2860
Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Serum progesterone levels pred ...... uman menopausal gonadotropins.
@en
Serum progesterone levels pred ...... uman menopausal gonadotropins.
@nl
type
label
Serum progesterone levels pred ...... uman menopausal gonadotropins.
@en
Serum progesterone levels pred ...... uman menopausal gonadotropins.
@nl
prefLabel
Serum progesterone levels pred ...... uman menopausal gonadotropins.
@en
Serum progesterone levels pred ...... uman menopausal gonadotropins.
@nl
P2093
P356
P1476
Serum progesterone levels pred ...... uman menopausal gonadotropins.
@en
P2093
P304
P356
10.1210/JCEM-73-4-797
P407
P577
1991-10-01T00:00:00Z